Amarin Corporation PLC. Daily Stock Analysis

Daily Stock Analysis, AMRN, Amarin Corporation PLC, priceseries

Amarin Corporation PLC. Daily Stock Analysis
Stock Information
Open
3.07
Close
3.00
High
3.13
Low
2.99
Previous Close
3.09
Daily Price Gain
-0.09
YTD High
3.82
YTD High Date
Feb 10, 2022
YTD Low
2.79
YTD Low Date
Jan 24, 2022
YTD Price Change
-0.51
YTD Gain
-14.53%
52 Week High
7.30
52 Week High Date
Mar 17, 2021
52 Week Low
2.79
52 Week Low Date
Jan 24, 2022
52 Week Price Change
-2.79
52 Week Gain
-48.19%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 2. 2017
2.96
Feb 22. 2017
3.40
13 Trading Days
14.90%
Link
LONG
Jun 19. 2017
3.00
Jul 13. 2017
4.00
17 Trading Days
33.38%
Link
LONG
Sep 22. 2017
3.29
Oct 10. 2017
3.47
12 Trading Days
5.53%
Link
LONG
Dec 15. 2017
3.39
Jan 16. 2018
4.16
19 Trading Days
22.69%
Link
LONG
Sep 24. 2018
12.40
Oct 30. 2018
20.02
26 Trading Days
61.42%
Link
LONG
Jan 9. 2019
15.03
Jan 28. 2019
16.49
12 Trading Days
9.73%
Link
LONG
Feb 21. 2019
17.43
Mar 13. 2019
20.62
14 Trading Days
18.31%
Link
LONG
Oct 10. 2019
14.91
Oct 29. 2019
15.98
13 Trading Days
7.19%
Link
LONG
Apr 22. 2020
6.68
May 1. 2020
7.40
7 Trading Days
10.76%
Link
LONG
Sep 29. 2020
4.04
Oct 14. 2020
4.95
11 Trading Days
22.54%
Link
LONG
Jan 7. 2021
5.66
Feb 10. 2021
8.08
23 Trading Days
42.82%
Link
LONG
Aug 2. 2021
4.22
Aug 30. 2021
5.57
20 Trading Days
31.99%
Link
Company Information
Stock Symbol
AMRN
Exchange
NasdaqGM
Company URL
http://www.amarincorp.com
Company Phone
ELY CAMBRIDGESHIRE X0 FK7 9JQ
CEO
John F. Thero
Headquarters
-
Business Address
-
Sector
Equity
Industry Category
Drugs
Industry Group
Drug Manufacturers - Other
CIK
0001120246
About

Amarin Corp. Plc is a biopharmaceutical company, which engages in the commercialization and development of therapeutics for cardiovascular health. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Description

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. Amarin Corporation plc sells its product principally to wholesalers and specialty pharmacy providers. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading